Scientists track immunotherapy side effects to make cancer treatment safer
NCT ID NCT05331066
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 200 cancer patients starting immunotherapy (checkpoint inhibitors) to understand why some develop immune-related side effects. Researchers will collect blood samples and clinical data to find early warning signs. The goal is to improve how doctors monitor and manage these side effects, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict and manage side effects from immunotherapy, making cancer treatment safer and more personalized.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly benefit participants. Results may take years to translate into clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Marsden NHS Foundation Trust
RECRUITINGChelsea, London, SW3 6JJ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a breathing exercise and music tame cancer treatment fatigue?
- Can a Finger-Prick replace the lab draw? a device puts accuracy to the test
- Exercise may boost immunotherapy in kidney cancer
- Scientists test novel way to detect pancreatic cancer from biopsy fluid
- Can exercise help cancer patients? new study aims to find out
- Simple exercises ease chemo nerve damage in new study